Cue Biopharma
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | 1,481.1 | 19,798.0 | 225.6 | 85.2 | 120.7 | 85.0 | 68.8 | 111.0 | 94.6 | 172.5 | 120.1 | 117.5 | 97.5 | 66.8 | 63.8 | 23.8 | 11.1 | 7.6 | 8.3 | 91.2 | 372.1 | 92.7 | 27.9 | 22.3 | 13.4 | 7.3 | 4.1 | 8.8 | 8.5 | 7.9 | 10.2 | 1.2 | 1.0 | 5.3 | |
| – | – | – | – | – | – | 5.1 | 146.0 | 4.6 | 2.9 | 6.4 | 9.2 | 7.0 | 7.0 | 8.3 | 8.6 | 5.1 | 4.7 | 5.3 | 5.0 | 7.2 | 5.4 | 2.5 | 1.5 | 1.5 | 1.7 | 2.9 | 3.6 | 2.5 | 3.3 | 3.1 | 2.8 | 1.5 | 4.7 | 10.3 | 3.6 | 5.5 | 1.3 | 1.5 | 86.7 | |
| – | – | – | – | – | – | 1,215.2 | 19,672.1 | 207.8 | – | 110.6 | 75.8 | 59.0 | 99.5 | 89.9 | 158.7 | 102.1 | 95.3 | 79.6 | 54.2 | 54.9 | 20.0 | 7.5 | 3.0 | 6.9 | 60.5 | 272.7 | 70.6 | 16.9 | 15.6 | 9.0 | 4.8 | 1.5 | 7.2 | 7.7 | 5.1 | 9.1 | 0.3 | 0.6 | 4.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.5 | 6.5 | 4.1 | 3.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -7.0% | -0.3% | -14.3% | -29.0% | -16.5% | -13.8% | -15.1% | -8.0% | 28.5% | 15.5% | 24.2% | 29.0% | -9.3% | -10.3% | -7.9% | -11.2% | -24.3% | -47.3% | -54.1% | -37.0% | -25.6% | -23.3% | -37.1% | -32.6% | -41.5% | -64.1% | -98.8% | -44.6% | -51.6% | -43.5% | -41.1% | -64.8% | -74.2% | -25.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -11,653.1% | -6,634.3% | -3,687.7% | -2,399.6% | -2,238.3% | -1,367.7% | -898.1% | -694.8% | -628.1% | -655.7% | -771.9% | -963.5% | -778.7% | -523.2% | -428.7% | -176.9% | -189.4% | -263.7% | -314.5% | -2,734.9% | -5,736.1% | -773.6% | -345.6% | -309.1% | -220.0% | -170.7% | -41.5% | 100.0% | 100.0% | 100.0% | 98.9% | 99.7% | 99.8% | 99.7% | |
| – | – | – | – | – | – | -14,348.6% | -8,392.5% | -4,703.4% | -3,388.7% | -3,225.2% | -2,013.2% | -1,413.3% | -1,063.2% | -961.2% | -999.1% | -1,155.6% | -1,428.0% | -1,170.5% | -802.9% | -653.6% | -292.7% | -315.9% | -413.2% | -494.8% | -4,275.1% | -12,122.0% | -2,952.7% | -1,392.2% | -949.9% | -732.7% | -582.2% | -479.4% | -446.9% | -514.7% | -475.2% | -536.8% | -96.6% | -59.8% | -262.0% | |
| – | – | – | – | – | – | -14,349.1% | -8,345.4% | -4,657.7% | -3,413.5% | -3,234.5% | -2,039.8% | -1,438.2% | -1,061.1% | -959.0% | -986.9% | -1,142.6% | -1,419.8% | -1,168.1% | -802.7% | -654.5% | -295.6% | -319.1% | -418.3% | -500.6% | -4,257.8% | -12,005.6% | -2,899.4% | -1,358.4% | -924.1% | -711.8% | -566.0% | -468.0% | -438.0% | -507.9% | -469.3% | -530.7% | -96.9% | -59.6% | -435.8% | |
| – | – | – | – | – | – | -10,370.9% | -6,459.2% | -3,222.0% | -2,473.8% | -1,992.1% | -1,169.7% | -1,037.1% | -891.9% | 2,691.6% | 2,670.0% | 2,902.5% | 3,409.8% | -908.5% | -687.3% | -505.6% | -266.0% | -270.4% | -358.0% | -450.4% | -3,371.6% | -9,539.3% | -2,162.6% | -1,034.5% | -727.9% | -555.1% | -465.2% | -402.0% | -391.9% | -436.5% | -341.7% | -420.0% | -79.6% | -75.2% | -133.2% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | -50.5% | -63.3% | -145.8% | -357.0% | -37.7% | -49.6% | -61.5% | -96.0% | -114.8% | -172.8% | -221.7% | -145.8% | -67.2% | -84.5% | -49.4% | -48.7% | -56.8% | -63.8% | -60.2% | -73.8% | -67.4% | -71.0% | -81.7% | -92.2% | -80.7% | -94.3% | -112.7% | -121.6% | -136.8% | -166.4% | -217.2% | -175.9% | -232.4% | -616.8% | -214.2% | -284.5% | -100.6% | -90.4% | -7,104.2% | |
| – | -47.0% | -93.9% | -123.3% | -248.4% | -34.7% | -46.2% | -57.0% | -84.8% | -86.0% | -94.6% | -107.7% | -87.2% | -51.2% | -63.1% | -39.0% | -40.0% | -45.0% | -50.1% | -49.0% | -59.4% | -53.0% | -50.6% | -57.6% | -61.3% | -58.1% | -63.5% | -70.9% | -75.3% | -82.5% | -92.6% | -110.9% | -99.6% | -126.4% | -182.4% | -95.5% | -119.1% | -63.0% | -63.2% | -534.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | -61 | -51 | -46 | -14 | – | -13 | -20 | -27 | -40 | -19 | -56 | -67 | -70 | -68 | -69 | -64 | -57 | -53 | -53 | -13 | -38 | -43 | -39 | -42 | -37 | -31 | -21 | -24 | -15 | -6.2 | -23 | -8.2 | -25 | -15 | -16 | |
| – | 93.2% | 148.2% | 84.6% | 69.6% | 92.0% | 93.1% | 92.7% | 88.4% | 74.9% | 54.7% | 48.6% | 59.8% | 76.2% | 74.6% | 79.1% | 82.1% | 79.3% | 78.5% | 81.3% | 80.5% | 78.5% | 71.3% | 70.5% | 66.5% | 72.0% | 67.4% | 62.9% | 61.9% | 60.3% | 55.7% | 51.1% | 56.6% | 54.4% | 29.6% | 44.6% | 41.9% | 62.6% | 70.0% | 7.5% | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.4 | 1.1 | 0.2 | 0.3 | 0.1 | 0.1 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -9.80 | -11.13 | -13.97 | -18.36 | -22.73 | -33.77 | -40.98 | -1.50 | -56.36 | -56.48 | -61.90 | -64.79 | -52.65 | -45.59 | -43.18 | -42.05 | -43.10 | -45.31 | -43.84 | -42.18 | -44.91 | -42.04 | -42.20 | -41.44 | -39.68 | -40.60 | -34.85 | -34.72 | -33.58 | -32.28 | -30.31 | -28.08 | -26.12 | -16.44 | -16.40 | -12.22 | -11.21 | -7.22 | -4.06 | -25.88 | |
| – | – | – | – | 0.00 | 0.00 | 0.29 | 0.02 | 1.21 | 1.65 | 1.91 | 3.18 | 3.66 | 4.30 | 4.50 | 4.26 | 3.77 | 3.19 | 3.75 | 5.26 | 6.86 | 14.22 | 13.23 | 9.91 | 7.93 | 0.95 | 0.29 | 1.20 | 2.47 | 3.49 | 4.26 | 4.96 | 5.58 | 3.75 | 3.23 | 2.60 | 2.11 | 7.46 | 6.81 | 5.94 | |
| – | 22.06 | 22.06 | 12.59 | 6.37 | 89.54 | 82.60 | 2.45 | 58.72 | 49.19 | 35.82 | 29.22 | 36.11 | 67.81 | 51.08 | 85.21 | 88.58 | 79.84 | 68.67 | 70.03 | 60.85 | 62.34 | 59.45 | 50.70 | 43.04 | 50.30 | 36.96 | 30.81 | 27.61 | 23.60 | 18.22 | 12.93 | 14.85 | 7.07 | 2.66 | 5.71 | 3.94 | 7.18 | 4.49 | 0.36 | |
| – | -9.42 | -13.40 | -16.74 | -19.74 | -19.47 | -29.62 | -1.16 | -38.99 | -40.93 | -38.12 | -37.15 | -37.97 | -38.32 | 121.21 | 113.77 | 109.49 | 108.82 | -34.09 | -36.12 | -34.69 | -37.84 | -35.76 | -35.46 | -35.70 | -32.15 | -27.69 | -25.89 | -25.57 | -25.43 | -23.63 | -23.08 | -22.44 | -14.71 | -14.09 | -8.90 | -8.87 | -5.94 | -5.12 | -7.91 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.